Vanguard Personalized Indexing Management LLC increased its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 1.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,706 shares of the biopharmaceutical company’s stock after buying an additional 261 shares during […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group cut shares of Horizon Therapeutics Public from a buy rating to a hold rating in a report on Friday, […]
Privium Fund Management B.V. bought a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 22,447 shares of the biopharmaceutical company’s stock, valued at approximately $2,316,000. Other institutional investors have also modified […]
Stock Analysts’ upgrades for Wednesday, September 13th: American Electric Power (NASDAQ:AEP) was upgraded by analysts at LADENBURG THALM/SH SH from a sell rating to a neutral rating. Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) was upgraded by analysts at StockNews.com to a […]
Boothbay Fund Management LLC lifted its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 276.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 85,275 shares of the biopharmaceutical company’s stock after acquiring an additional 62,633 shares […]